Register Now

Peter Farmakis

CEO, 32 Biosciences

32 Biosciences “Three Squared Biosciences” is building companies that are leveraging artificial intelligence to better understand the gut microbiome, and utilizing this information to create therapies that modulate the gut microbiome to prevent diseases. Current company portfolio includes: Gateway Biome & Covira.

Peter Farmakis is an accomplished executive with diversified leadership experiences in the life science industry including; biotech/pharmaceuticals, medical devices, and diagnostics/molecular diagnostics.

Throughout his career Peter has held multiple commercial leadership positions with two large industry leading diversified life science organizations Johnson & Johnson and Abbott Laboratories, and six privately held early-stage/start-up companies including Gateway Biome, Covira, VitaHEAT Medical, OraPharma, Unimed Pharmaceuticals, and DynaSplint Systems.

Peter completed the General Management Executive Development Program from Northwestern University – Kellogg School of Management. Peter attained his MBA in Marketing and Strategic Management from the University of Illinois at Chicago, and his BA in Pre-Physical Therapy and Psychology from the University of Illinois at Chicago.

Peter’s board experience includes Board of Directors for Gateway Biome, Board of Directors for Covira, CEO Leadership on the Ops Team for Smart Health Catalyst, and past Boards of Director roles including VitaHEAT Medical and Health Industry Supply Chain Institute.